Statistics on Biotechnology Use  
Results by sector of operation
Sector Companies. Results in biotechnology for main variables and branches of activity 
Unidades: specified in variables

,Total Companies,Services,Industry and Construction,Agriculture,
No. of companies carrying out R&D in Biotechnology,1.079,679,320,81,
%Companies according to biotechnology used: Genetic code,35,42,17,46,
%Companies according to biotechnology used: Functional units,44,48,41,27,
%Companies according to biotechnology used: Cellular and tissue culturing and engineering,26,31,16,26,
%Companies according to biotechnology used: Bioprocesses,49,40,75,29,
%Companies according to biotechnology used: Sub-cellular organisms,8,11,5,2,
%Companies according to biotechnology used: Bio-computing,23,32,8,5,
%Companies according to biotechnology used: Nanobiotechnology,15,20,7,2,
%Companies according to biotechnology used: Other,12,13,9,22,
Companies in which biotechnology activities are: Main and/or exclusive,519,436,72,11,
Companies in which biotechnology activities are: A secondary line of business,179,107,57,15,
Companies in which biotechnology activities are: A tool necessary for production,381,136,190,55,
%Company by field(s) of ultimate application of biotechnology use: Human Health,48,62,28,3,
%Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture,21,23,13,36,
%Company by field(s) of ultimate application of biotechnology use: Food products,33,25,51,33,
%Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production,22,19,18,58,
%Company by field(s) of ultimate application of biotechnology use: Environment,17,18,19,11,
%Company by field(s) of ultimate application of biotechnology use: Industry,15,17,13,3,
Personnel in R&D in biotechnology (no. of persons),9.795,6.459,2.590,745,
Personnel in R&D in biotechnology (no. of persons): Researchers,5.573,4.149,1.190,234,
Personnel in R&D in biotechnology (no. of persons): Technicians and assistants,4.222,2.310,1.401,511,
Personnel in R&D in biotechnology (no. of persons): women,5.298,3.701,1.308,290,
Personnel in R&D in biotechnology (no. of persons): (women) Researchers,2.925,2.230,611,84,
Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants,2.373,1.471,696,206,
Personnel in R&D in biotechnology (FTE),6.828,6,4.786,1,1.592,7,449,8,
Personnel in R&D in biotechnology (FTE): Researchers,4.106,5,3.140,9,811,9,153,7,
Personnel in R&D in biotechnology (FTE): Technicians and assistants,2.722,1,1.645,2,780,8,296,2,
Personnel in R&D in biotechnology (FTE): women,3.811,7,2.728,883,7,200,
Personnel in R&D in biotechnology (FTE): (women) Researchers,2.190,7,1.684,7,447,7,58,4,
Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants,1.621,1.043,4,436,141,6,
Internal expenditure on R&D (thousands of euros),533.826,357.195,150.471,26.160,
1) By nature of the expense: Current expenses,492.955,329.995,141.459,21.501,
1.1) Remuneration to researchers,203.439,144.769,51.775,6.895,
1.2) Remuneration to technicians and assistants,96.850,50.585,38.481,7.784,
1.3) Other current expenses,192.666,134.641,51.202,6.822,
2) By nature of the expense: Capital expenses,40.870,27.199,9.012,4.659,
2.1) Land and buildings,7.521,3.248,1.126,3.147,
2.2) Equipment and instruments,32.078,22.730,7.856,1.492,
2.3) Acquisition of specific R&D software,1.270,1.221,29,20,
1) By origin of the funds: National funds,432.869,285.287,122.831,24.752,
1.1) Own funds,319.046,179.647,116.254,23.144,
1.2) From companies,39.253,38.264,989,0,
1.3) Public Administration funds,70.063,62.869,5.587,1.607,
1.4) From Universities,156,156,0,0,
1.5) From non profit private institutions,4.351,4.351,0,0,
1) By origin of the funds: Foreign funds,100.956,71.908,27.640,1.409,
2.1) From EU programmes,20.070,18.776,886,408,
2.2) Other foreign funds,80.886,53.131,26.754,1.001,
Purchase of R&D services in biotechnology (thousands of euros),138.625,52.251,83.896,2.478,
Purchase of R&D services in biotechnology (thousands of euros): In Spain,101.114,41.915,57.089,2.109,
Purchase of R&D services in biotechnology (thousands of euros): Abroad,37.512,10.336,26.807,369,
%Companies that consider the following obstacles as very important considering biotechnology development: Access to capital,46,56,30,31,
%Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information,13,11,16,14,
%Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources,12,13,11,12,
%Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain,14,16,13,7,
%Companies that consider the following obstacles as very important considering biotechnology development: Lack of access to international markets,19,21,17,8,
%Companies that consider the following obstacles as very important considering biotechnology development: Lack of distribution and sales channels,19,24,13,6,
%Companies that consider the following obstacles as very important considering biotechnology development: Acceptance / public perception,18,20,13,17,
%Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements,37,39,35,22,
%Companies that consider the following obstacles as very important considering biotechnology development: Time / cost,49,52,44,46,
%Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting,19,21,17,12,
% Companies that have requested biotechnology patents in Biotechnology,15,19,10,3,
Number of patents requested,466,338,101,27,
% Companies with income of an international origin related to biotechnological activities,24,9,27,23,8,11,9,
% Turnover representing income of an international origin related to biotechnological activities,0,9,4,5,0,8,1,1,
% Income of an international origin related to biotechnological activities distributed in: Income received from the EU,71,3,51,6,76,3,24,5,
% Income of an international origin related to biotechnological activities distributed in: Income received from other countries,28,7,48,4,23,7,75,5,
% Income of an international origin related to biotechnological activities by classification: Internacional trade in products and services,92,2,55,4,99,5,92,4,
% Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain,2,4,14,1,0,4,1,
% Income of an international origin related with activities according to the classification: Operating source abroad,1,3,7,0,1,.,
% Income of an international origin related with activities according to the classification: Other,4,2,23,5,0,4,3,5,
Notas:

.
'.'=numeric piece of data equal to zero not resulting from rounding 

 FTE: Full Time Equivalent
Fuente: National Statistics Institute